Disruption of Transforming Growth Factor β Signaling and Profibrotic Responses in Normal Skin Fibroblasts by Peroxisome Proliferator-Activated Receptor γ

Arthritis and Rheumatism

Volumn 50, Issue 4, 2004, Pages 1305-1318

  Ghosh, Asish K ^a   Bhattacharyya, Swati ^a   Lakos, Gabriella ^a   Chen, Shu Jen ^a   Mori, Yasuji ^a   Varga, John ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; RECEPTOR BLOCKING AGENT; SMAD PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FIBROSIS; FLOW CYTOMETRY; GENE ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MODULATION; MYOFIBROBLAST; NORMAL HUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SCLERODERMA; SKIN FIBROBLAST; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ACTINS; CELLS, CULTURED; COLLAGEN; DERMIS; DNA-BINDING PROTEINS; FIBROBLASTS; FIBROSIS; GENE EXPRESSION; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 1842733168     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20104     Document Type: Article

References (59)

1. Ihn H. Pathogenesis of fibrosis: role of TGFβ and CTGF. Curr Opin Rheumatol 2002;14:681-5.
2. Jelaska A, Korn JH. Role of apoptosis and transforming growth factor β1 in fibroblast selection and activation in systemic sclerosis. Arthritis Rheum 2000;43:2230-9.
3. Miyazono K, ten Dijke P, Heldin CH. TGF-β signaling by SMAD proteins. Adv Immunol 2000;75:115-57.
4. Massague J, Wotton D. Transcriptional control by the TGF-β/ Smad signaling system. EMBO J 2002;19:1745-54.
5. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of SMAD 3. J Invest Dermatol 1999;112:49-57.
6. Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J. Interaction of Smad3 with a proximal Smad-binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF-β. J Cell Physiol 2000;183:381-92.
7. Ghosh AK, Yuan W, Mori Y, Varga J. SMAD-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000;19:3546-55.
8. Ghosh AK, Yuan W, Mori Y, Chen SJ, Varga J. Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β: integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 2001;276:11041-8.
9. Mori Y, Chen SJ, Varga J. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Arthritis Rheum 2003;48:1964-78.
10. Varga J. Scleroderma and SMADs: dysfunctional SMAD family dynamics culminating in fibrosis. Arthritis Rheum 2002;46:1703-13.
11. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR γ2, a lipid-activated transcription factor. Cell 1994;79:1147-56.
12. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002;53:409-35.
13. Straus DS, Glass CK. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 2001;21:185-210.
14. Westin S, Kurokawa R, Nolte RT, Wisely GB, McInerney EM, Rose DW, et al. Interaction controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 1998;395:199-202.
15. Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli W, Meier CA, et al. DNA binding properties of peroxisome proliferators-activated receptor subtypes on various natural peroxisome proliferators response elements. J Biol Chem 1997;272:25252-9.
16. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, et al. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998;273:25573-80.
17. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000;106:189-97.
18. Simonin MA, Bordji K, Boyault S, Bianchi A, Gouze E, Becuwe P, et al. PPAR-γ ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am J Physiol Cell Physiol 2002;2282:C125-33.
19. 2 in activated human astrocytes, but not in human brain macrophages. J Immun 2002;168:4747-55.
20. 2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-γ-independent mechanism. Biochem Biophys Res Commun 2003;302:415-20.
21. Akahoshi T, Namai R, Murakami Y, Watanabe M, Matsui T, Nishimura A, et al. Rapid induction of peroxisome proliferator-activated receptor γ expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum 2003;48:231-9.
22. Pontsler AV, Hilaire AS, Marathe GK, Zimmerman GA, McIntyre TM. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferators activated receptor γ and oxidized alkyl phospholipids from oxidized low density lipoprotein. J Biol Chem 2002;277: 13029-36.
23. Routh RE, Johnson JH, McCarthy KJ. Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro. Kidney Int 2002;61:1365-76.
24. Zheng F, Fornoni A, Elliot SJ, Guan Y, Breyer MD, Striker LJ, et al. Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation. Am J Physiol Renal Physiol 2002; 282:F639-48.
25. Galli A, Crabb DW, Ceni E, Salzano R, Mello T, Svegliati-Baroni G, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002;122:1924-40.
26. Kon K, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Kitamura T, et al. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun 2002;291:55-61.
27. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, et al. Peroxisome proliferators-activated receptor and hepatic stellate cell activation. J Biol Chem 2000;275:35715-22.
28. Masamune A, Kikuta K, Satoh M, Sakai Y, Satoh A, Shimosegawa T. Ligands of peroxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells. J Biol Chem 2002;277:141-7.
29. McCarthy KJ, Routh RE, Shaw W, Walsh K, Welbourne TC, Johnson JH. Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion. Kidney Int 2000;58:2341-50.
30. Jia DM, Otsuki M. Troglitazone stimulates pancreatic growth in normal rats. Pancreas 2002;24:303-12.
31. Varga J, Rosenbloom J, Jimenez SA. Transforming growth factor β (TGF β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 1987;247:597-604.
32. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M. Transcriptional regulation of the human α2(I) collagen gene: combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem 1996;271:26717-23.
33. Park Y, Freedman BD, Lee EJ, Park S, Jameson JL. A dominant negative PPAR-γ mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3-L1 cells. Diabetologia 2003;46: 365-77.
34. Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C, et al. A dominant negative peroxisome proliferators-activated receptor γ (PPAR-γ) mutant is a constitutive repressor and inhibits PPAR-γ-mediated adipogenesis. J Biol Chem 2000;275:5754-9.
35. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, et al. Human SMAD3 and SMAD4 are sequence-specific transcription activators. Mol Cell 1998;1:611-7.
36. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type I gene. EMBO J 1998;17:3091-100.
37. Mori Y, Chen SJ, Varga J. Modulation of endogenous SMAD expression in normal skin fibroblasts by transforming growth factor-β. Exp Cell Res 2000;258:374-83.
38. Oates JC, Reilly CM, Crosby MB, Gilkeson GS. Peroxisome proliferator-activated receptor γ agonists: potential use for treating chronic inflammatory diseases. Arthritis Rheum. 2002;46: 598-605.
39. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, et al. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature 1999;400:378-82.
40. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3:349-63.
41. Evans RA, Tian YC, Steadman R, Phillips AO. TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-the role of SMAD proteins. Exp Cell Res 2003;282:90-100.
42. Hu B, Wu Z, Phan SH. Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression. Am J Respir Cell Mol Biol 2003;29:397-404.
43. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, et al. A mechanism of suppression of TGF-β/ SMAD signaling by NF-κB/RelA. Genes Dev 2000;14:187-97.
44. Ulloa L, Doody J, Massague J. Inhibition of transforming growth factor-β/Smad signaling by the interferon-γ/STAT pathway. Nature 1999;397:710-3.
45. Patil S, Wildey GM, Brown TL, Choy L, Derynck R, Howe PH. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-γ-induced growth inhibition and apoptosis. J Biol Chem 2000;275:38363-70.
46. Dong C, Zhu S, Wang T, Yoon W, Li Z, Alvarez RJ, et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci U S A 2002;99:3908-13.
47. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001; 7:48-52.
48. Fu M, Zhang J, Zhu X, Myles DE, Willson TM, Liu X, et al. Peroxisome proliferator-activated receptor γ inhibits transforming growth factor-β-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 2001;276:45888-94.
49. Fu M, Zhang J, Lin Y, Zhu X, Zhao L, Ahmad M, et al. Early stimulation and late inhibition of peroxisome proliferators-activated receptor γ (PPAR-γ) gene expression by transforming growth factor β in human aortic smooth muscle cells: role of early growth-response factor-1 (EGR-1), activator protein 1 (AP1) and Smads. Biochem J 2003;370:1019-25.
50. Leesnitzer LM, Parks DL, Bledsoe RK, Cobb JE, Collins JL, Consler TG, et al. Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferators activated receptors by GW9662. Biochemistry 2002;41:6640-50.
51. Ghosh AK. Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med 2002;227:301-14.
52. Ihn H, LeRoy EC, Trojanowska M. Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site. J Biol Chem 1997;272:24666-72.
53. Chen SJ, Artlett CM, Jimenez SA, Varga J. Modulation of human α1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene 1998;215:101-10.
54. Poncelet AC, Schnaper HW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 2001;276:6983-92.
55. Chung KY, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human α2(I) collagen (COL1A2) promoter activity by transforming growth factor-β. J Biol Chem 1996;271:3272-8.
56. Ghosh AK, Varga J. Transcriptional coactivators p300/CBP and type I collagen gene expression. Curr Sci 2003;85:155-61.
57. Hayashida T, Poncelet AC, Hubchak SC, Scnaper HW. TGF-β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int 1999;56:1710-20.
58. Chin BY, Mohsenin A, Li SX, Choi AM, Choi ME. Stimulation of pro-α1(I) collagen by TGF-β1 in mesangial cells: role of the p38 MAPK pathway. Am J Physiol Renal Physiol 2001;280:F495-504.
59. Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. Cross-talk between transforming growth factor-β and estrogen receptor signaling through Smad3. J Biol Chem 2001;276:42908-14.